•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S01267 Summary:

BILL NOS01267A
 
SAME ASSAME AS A00901-A
 
SPONSORBRESLIN
 
COSPNSRADDABBO, FERNANDEZ, MAY, SKOUFIS
 
MLTSPNSR
 
Amd §§4902 & 4903, Ins L; amd §§4902 & 4903, Pub Health L
 
Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.
Go to top    

S01267 Actions:

BILL NOS01267A
 
01/11/2023REFERRED TO INSURANCE
01/17/2023REPORTED AND COMMITTED TO RULES
01/17/2023ORDERED TO THIRD READING CAL.85
01/17/2023PASSED SENATE
01/17/2023DELIVERED TO ASSEMBLY
01/17/2023referred to insurance
01/03/2024died in assembly
01/03/2024returned to senate
01/03/2024REFERRED TO INSURANCE
01/08/20241ST REPORT CAL.92
01/09/20242ND REPORT CAL.
01/16/2024ADVANCED TO THIRD READING
01/30/2024PASSED SENATE
01/30/2024DELIVERED TO ASSEMBLY
01/30/2024referred to insurance
05/15/2024RECALLED FROM ASSEMBLY
05/15/2024returned to senate
05/15/2024VOTE RECONSIDERED - RESTORED TO THIRD READING
05/15/2024AMENDED ON THIRD READING 1267A
05/21/2024REPASSED SENATE
05/21/2024RETURNED TO ASSEMBLY
05/21/2024referred to insurance
06/03/2024substituted for a901a
06/03/2024ordered to third reading rules cal.299
06/05/2024passed assembly
06/05/2024returned to senate
12/12/2024DELIVERED TO GOVERNOR
12/21/2024SIGNED CHAP.641
12/21/2024APPROVAL MEMO.72
Go to top